axitinib
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In neat (no solvent) for 0.75h; Milling; | 99% |
With toluene-4-sulfonic acid In methanol; water at 64℃; for 1 - 5h; Product distribution / selectivity; | 98% |
With toluene-4-sulfonic acid In methanol; water at 65℃; for 4h; Reagent/catalyst; Inert atmosphere; | 95.4% |
axitinib
Conditions | Yield |
---|---|
With 1,2-diaminopropan In 1-methyl-pyrrolidin-2-one at 40 - 70℃; for 1h; | 95% |
axitinib
Conditions | Yield |
---|---|
In methanol; acetic acid at 60℃; | 92% |
Stage #1: 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole ethylacetate solvate With toluene-4-sulfonic acid In ethanol at 82℃; for 14h; Stage #2: With sodium hydrogencarbonate In ethanol; water at 20℃; for 2h; |
axitinib
Conditions | Yield |
---|---|
In NaHCO3; ethyl acetate at 65℃; | 92% |
2-vinylpyridine
2-((3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
Stage #1: 2-((3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide With palladium diacetate; acetic anhydride; N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In 1-methyl-pyrrolidin-2-one at 25 - 50℃; Inert atmosphere; Stage #2: 2-vinylpyridine In 1-methyl-pyrrolidin-2-one at 50 - 95℃; for 12h; | 70.68% |
With tris-(o-tolyl)phosphine; lithium bromide; palladium diacetate In 2,4-dichlorophenoxyacetic acid dimethylamine at 110℃; for 25h; Product distribution / selectivity; Heck Reaction; | |
With N,N,N',N'-tetramethyl-1,8-diaminonaphthalene; tris-(o-tolyl)phosphine; lithium bromide; palladium diacetate In DMA at 110℃; for 25h; Product distribution / selectivity; Inert atmosphere; |
Conditions | Yield |
---|---|
With triethylamine In neat (no solvent) at 100℃; for 24h; Heck Reaction; Green chemistry; | 70% |
2-mercapto-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
With palladium diacetate; N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In 1,4-dioxane for 48h; Inert atmosphere; Reflux; | 54% |
2-vinylpyridine
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: palladium diacetate; triethylamine; triphenylphosphine; tetrabutylammomium bromide; sodium bromide / neat (no solvent) / 1.5 h / Milling 2: tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / neat (no solvent) / 0.83 h / Milling 3: toluene-4-sulfonic acid / neat (no solvent) / 0.75 h / Milling View Scheme |
2-vinylpyridine
axitinib
Conditions | Yield |
---|---|
Stage #1: 2-vinylpyridine; N-1 Boc 2-(3-iodo-1H-indazol-6-ylsulfanyl)-N-methyl-benzamide for 2h; Heck Reaction; Stage #2: With tris-(o-tolyl)phosphine; palladium diacetate In N,N-dimethyl-formamide at 100℃; Stage #3: With trifluoroacetic acid Product distribution / selectivity; |
axitinib
Conditions | Yield |
---|---|
In tetrahydrofuran at 20 - 65℃; for 18h; Purification / work up; |
axitinib
Conditions | Yield |
---|---|
With trifluoroacetic acid In N,N-dimethyl-formamide |
6-Iodo-1H-indazole
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1.1: 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; sodium hydrogencarbonate; tris-(dibenzylideneacetone)dipalladium(0) / 1-methyl-pyrrolidin-2-one / 0.5 h / 25 °C / Inert atmosphere; Large scale 1.2: 3 h / 25 - 50 °C / Inert atmosphere; Large scale 2.1: iodine; potassium hydroxide / 1-methyl-pyrrolidin-2-one; water / 5.5 h / 25 °C / Inert atmosphere; Large scale 3.1: N-ethyl-N,N-diisopropylamine; palladium diacetate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1-methyl-pyrrolidin-2-one / 50 °C / Inert atmosphere; Large scale 4.1: 1-methyl-pyrrolidin-2-one / 50 - 90 °C / Inert atmosphere; Large scale 5.1: 1,2-diaminopropan / water; tetrahydrofuran / 12.5 h / 50 °C / Inert atmosphere; Large scale View Scheme |
2-((1H-indazol-6-yl)thio)-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: iodine; potassium hydroxide / 1-methyl-pyrrolidin-2-one; water / 5.5 h / 25 °C / Inert atmosphere; Large scale 2: N-ethyl-N,N-diisopropylamine; palladium diacetate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1-methyl-pyrrolidin-2-one / 50 °C / Inert atmosphere; Large scale 3: 1-methyl-pyrrolidin-2-one / 50 - 90 °C / Inert atmosphere; Large scale 4: 1,2-diaminopropan / water; tetrahydrofuran / 12.5 h / 50 °C / Inert atmosphere; Large scale View Scheme |
2-((3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: N-ethyl-N,N-diisopropylamine; palladium diacetate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1-methyl-pyrrolidin-2-one / 50 °C / Inert atmosphere; Large scale 2: 1-methyl-pyrrolidin-2-one / 50 - 90 °C / Inert atmosphere; Large scale 3: 1,2-diaminopropan / water; tetrahydrofuran / 12.5 h / 50 °C / Inert atmosphere; Large scale View Scheme |
N-methyl-2-((1-acetyl-3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)benzamide
axitinib
Conditions | Yield |
---|---|
With 1,2-diaminopropan In tetrahydrofuran; water at 50℃; for 12.5h; Inert atmosphere; Large scale; | 28.0 kg |
2-mercapto-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1.1: 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; sodium hydrogencarbonate; tris-(dibenzylideneacetone)dipalladium(0) / 1-methyl-pyrrolidin-2-one / 0.5 h / 25 °C / Inert atmosphere; Large scale 1.2: 3 h / 25 - 50 °C / Inert atmosphere; Large scale 2.1: iodine; potassium hydroxide / 1-methyl-pyrrolidin-2-one; water / 5.5 h / 25 °C / Inert atmosphere; Large scale 3.1: N-ethyl-N,N-diisopropylamine; palladium diacetate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1-methyl-pyrrolidin-2-one / 50 °C / Inert atmosphere; Large scale 4.1: 1-methyl-pyrrolidin-2-one / 50 - 90 °C / Inert atmosphere; Large scale 5.1: 1,2-diaminopropan / water; tetrahydrofuran / 12.5 h / 50 °C / Inert atmosphere; Large scale View Scheme |
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1.1: methanesulfonic acid / tetrahydrofuran / 6 h / Reflux 2.1: sodiumsulfide nonahydrate / water; methanol / 60 °C 3.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 3.2: 5.5 h / 0 °C 4.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 5.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
(Ε)-6-nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)indazole
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1.1: sodiumsulfide nonahydrate / water; methanol / 60 °C 2.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 2.2: 5.5 h / 0 °C 3.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 4.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme | |
Multi-step reaction with 4 steps 1.1: ammonium chloride; iron / water; ethanol / 2 h / 50 °C 2.1: sodium nitrite; acetic acid / water / 2 h / 0 °C 2.2: 1.17 h / 0 °C 2.3: 2.08 h / 0 °C 3.1: bis[1,2-bis(diphenylphosphino)ferrocene]-palladium(0); caesium carbonate / N,N-dimethyl-formamide / 16 h / 80 °C / Inert atmosphere 4.1: toluene-4-sulfonic acid / water; methanol / 4 h / 65 °C / Inert atmosphere View Scheme |
(Ε)-6-amino-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)indazole
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 1.2: 5.5 h / 0 °C 2.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 3.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme | |
Multi-step reaction with 3 steps 1.1: sodium nitrite; acetic acid / water / 2 h / 0 °C 1.2: 1.17 h / 0 °C 1.3: 2.08 h / 0 °C 2.1: bis[1,2-bis(diphenylphosphino)ferrocene]-palladium(0); caesium carbonate / N,N-dimethyl-formamide / 16 h / 80 °C / Inert atmosphere 3.1: toluene-4-sulfonic acid / water; methanol / 4 h / 65 °C / Inert atmosphere View Scheme |
6-nitroindazole
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 8 steps 1.1: potassium carbonate; iodine / N,N-dimethyl-formamide / 25 - 60 °C 2.1: potassium carbonate / N,N-dimethyl-formamide / 2.5 h / 60 °C 3.1: potassium carbonate; 1,10-Phenanthroline; copper(l) iodide / N,N-dimethyl-formamide / 8 h / 60 - 100 °C / Inert atmosphere 3.2: 60 °C 4.1: methanesulfonic acid / tetrahydrofuran / 6 h / Reflux 5.1: sodiumsulfide nonahydrate / water; methanol / 60 °C 6.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 6.2: 5.5 h / 0 °C 7.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 8.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme | |
Multi-step reaction with 7 steps 1.1: 2,3-dicyano-5,6-dichloro-p-benzoquinone / acetonitrile / 2 h / 82 °C 2.1: sodium hydroxide; iodine / N,N-dimethyl-formamide / 14 h / 10 - 25 °C 2.2: 0.5 h / 20 °C 3.1: N-ethyl-N,N-diisopropylamine; tris-(o-tolyl)phosphine; palladium dichloride / N,N-dimethyl-formamide / 12 h / 100 °C / Inert atmosphere 4.1: ammonium chloride; iron / water; ethanol / 2 h / 50 °C 5.1: sodium nitrite; acetic acid / water / 2 h / 0 °C 5.2: 1.17 h / 0 °C 5.3: 2.08 h / 0 °C 6.1: bis[1,2-bis(diphenylphosphino)ferrocene]-palladium(0); caesium carbonate / N,N-dimethyl-formamide / 16 h / 80 °C / Inert atmosphere 7.1: toluene-4-sulfonic acid / water; methanol / 4 h / 65 °C / Inert atmosphere View Scheme |
2-mercapto-N-methylbenzamide
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 2: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
2,2'-dithiobenzoic acid
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: thionyl chloride / N,N-dimethyl-formamide / 4 h / Reflux 2: tetrahydrofuran / 11 h / 0 - 20 °C / pH 9 - 10 3: sodium tetrahydroborate / tetrahydrofuran / 0 - 30 °C 4: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 5: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
2,2'-dithiodibenzoic acid dichloride
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: tetrahydrofuran / 11 h / 0 - 20 °C / pH 9 - 10 2: sodium tetrahydroborate / tetrahydrofuran / 0 - 30 °C 3: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 4: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
2,2'-dithiobis(N-methylbenzamide)
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: sodium tetrahydroborate / tetrahydrofuran / 0 - 30 °C 2: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 3: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
3-iodo-6-nitro-1H-indazole
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1.1: potassium carbonate / N,N-dimethyl-formamide / 2.5 h / 60 °C 2.1: potassium carbonate; 1,10-Phenanthroline; copper(l) iodide / N,N-dimethyl-formamide / 8 h / 60 - 100 °C / Inert atmosphere 2.2: 60 °C 3.1: methanesulfonic acid / tetrahydrofuran / 6 h / Reflux 4.1: sodiumsulfide nonahydrate / water; methanol / 60 °C 5.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 5.2: 5.5 h / 0 °C 6.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 7.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1.1: potassium carbonate; 1,10-Phenanthroline; copper(l) iodide / N,N-dimethyl-formamide / 8 h / 60 - 100 °C / Inert atmosphere 1.2: 60 °C 2.1: methanesulfonic acid / tetrahydrofuran / 6 h / Reflux 3.1: sodiumsulfide nonahydrate / water; methanol / 60 °C 4.1: acetic acid; sulfuric acid; sodium nitrite / water / 4 h / -5 - 0 °C 4.2: 5.5 h / 0 °C 5.1: potassium carbonate; copper(l) iodide; 2-vinylpyridine / N,N-dimethyl-formamide / 12 h / 100 °C 6.1: water; hydrogenchloride; methanol / 6 h / 60 °C View Scheme |
1,3-dibromobenzene
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: aluminum (III) chloride / 1 h / 100 °C / Inert atmosphere 2: potassium hydroxide / methanol; water / 1.5 h / 20 °C 3: hydrogenchloride / methanol; water / 12 h / 50 °C 4: copper(I) oxide / i-Amyl alcohol / 5 h / Inert atmosphere; Reflux 5: tetrabutyl ammonium fluoride / tetrahydrofuran / 12 h / 50 °C 6: N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; palladium diacetate / 1,4-dioxane / 48 h / Inert atmosphere; Reflux View Scheme |
2,4-dibromoacetophenone
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: potassium hydroxide / methanol; water / 1.5 h / 20 °C 2: hydrogenchloride / methanol; water / 12 h / 50 °C 3: copper(I) oxide / i-Amyl alcohol / 5 h / Inert atmosphere; Reflux 4: tetrabutyl ammonium fluoride / tetrahydrofuran / 12 h / 50 °C 5: N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; palladium diacetate / 1,4-dioxane / 48 h / Inert atmosphere; Reflux View Scheme |
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: hydrogenchloride / methanol; water / 12 h / 50 °C 2: copper(I) oxide / i-Amyl alcohol / 5 h / Inert atmosphere; Reflux 3: tetrabutyl ammonium fluoride / tetrahydrofuran / 12 h / 50 °C 4: N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; palladium diacetate / 1,4-dioxane / 48 h / Inert atmosphere; Reflux View Scheme |
axitinib
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: tetrabutyl ammonium fluoride / tetrahydrofuran / 12 h / 50 °C 2: N-ethyl-N,N-diisopropylamine; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; palladium diacetate / 1,4-dioxane / 48 h / Inert atmosphere; Reflux View Scheme |
Conditions | Yield |
---|---|
With palladium In 1-methyl-pyrrolidin-2-one; ethanol at 65 - 75℃; for 1h; Solvent; | 99.9% |
axitinib
acetyl chloride
N-methyl-2-((1-acetyl-3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)benzamide
Conditions | Yield |
---|---|
In dichloromethane at 20℃; for 16h; Cooling with ice; | 99% |
With triethylamine In dichloromethane at 20℃; for 16h; Cooling with ice; Inert atmosphere; | 99% |
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; for 16h; | 98% |
2,3-dihydro-2H-furan
axitinib
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 80℃; for 2h; | 96% |
axitinib
Conditions | Yield |
---|---|
Stage #1: axitinib; p-nitrophenyl 13,13,14,14-tetramethyl-3,6,9,12-tetraoxa-13-silapentadec-1-yl carbonate With triethylamine In N,N-dimethyl-formamide at 20℃; Stage #2: With hydrogenchloride; ethanol at 20℃; for 2h; | 95.3% |
axitinib
N-tert-butoxycarbonyl aspartic acid tert-butyl ester
Conditions | Yield |
---|---|
With diphenylphosphoranyl azide; triethylamine In N,N-dimethyl-formamide at 20℃; for 4h; | 93.6% |
Conditions | Yield |
---|---|
With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl-formamide at 20℃; for 4h; | 93.6% |
axitinib
formaldehyd
Conditions | Yield |
---|---|
With triethylamine In water; N,N-dimethyl-formamide at 0℃; for 3h; | 93% |
Conditions | Yield |
---|---|
In tetrahydrofuran at 80℃; for 7h; | 92% |
axitinib
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 89% |
With triethylamine In N,N-dimethyl-formamide at 20℃; | 89% |
axitinib
Conditions | Yield |
---|---|
Stage #1: axitinib; (2-(2-((tert-butyldimethylsilyl)oxy)ethoxy)ethyl)(4-nitrophenyl) carbonate With triethylamine In N,N-dimethyl-formamide at 20℃; Stage #2: With hydrogenchloride; ethanol at 20℃; for 2h; | 87.8% |
axitinib
di-tert-butyl dicarbonate
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 87% |
With triethylamine In N,N-dimethyl-formamide at 20℃; | 77% |
With triethylamine In N,N-dimethyl-formamide for 1h; | 4.1 g |
With triethylamine In N,N-dimethyl-formamide for 1h; | 4.1 g |
With triethylamine In N,N-dimethyl-formamide for 1h; | 4.1 g |
axitinib
t-butyl malonate
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 87% |
axitinib
Conditions | Yield |
---|---|
With hydrogen bromide In isopropyl alcohol at 20 - 50℃; | 84% |
axitinib
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 83.1% |
axitinib
Conditions | Yield |
---|---|
With hydrogenchloride In isopropyl alcohol at 20 - 50℃; | 83% |
axitinib
1-dodecyl p-nitrophenyl carbonate
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 82.3% |
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 82.3% |
axitinib
di-tert-butyl dicarbonate
Conditions | Yield |
---|---|
With dmap In dichloromethane at 25℃; for 16h; | 81.9% |
Conditions | Yield |
---|---|
In isopropyl alcohol at 20 - 50℃; | 81% |
axitinib
pivaloyl chloride
Conditions | Yield |
---|---|
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere; | 81% |
With triethylamine In dichloromethane at 20℃; Inert atmosphere; Cooling with ice; | 81% |
axitinib
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide | 81% |
axitinib
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; | 81% |
axitinib
(2-(2-methoxyethoxy)ethyl) (4-nitrophenyl) carbonate
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 80.6% |
axitinib
Conditions | Yield |
---|---|
Stage #1: axitinib; 4-nitrophenyl (2,2,3,3-tetramethyl-4,7,10-trioxa-3-siladodecan-12-yl) carbonate With triethylamine In N,N-dimethyl-formamide at 20℃; Stage #2: With hydrogenchloride; ethanol at 20℃; for 2h; | 79.8% |
axitinib
methyl (2-ethoxy)(4-nitrophenyl)carbonate
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 79.8% |
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 79.8% |
axitinib
4-nitrophenyl n-pentyl carbonate
Conditions | Yield |
---|---|
With triethylamine at 20℃; for 3h; | 77% |
With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; | 77% |
1. Introduction of Axitinib
Axitinib is one kind of white crystalline powder or off-white solid. The IUPAC name of Axitinib is N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide. The product's categories are All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Protein Kinase Inhibitors and Activators. It is a small molecule tyrosine kinase inhibitor under development by Pfizer. Axitinib can soluble in DMSO at 33 mg/mL; soluble in ethanol at 1.7 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
2. Properties of Axitinib
Physical properties about Axitinib are:
(1)ACD/LogP: 4.15; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 4.14; (4)ACD/LogD (pH 7.4): 4.15; (5)ACD/BCF (pH 5.5): 830.65; (6)ACD/BCF (pH 7.4): 834.47; (7)ACD/KOC (pH 5.5): 4273.12; (8)ACD/KOC (pH 7.4): 4292.77; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 76.32 Å2; (13)Index of Refraction: 1.728; (14)Molar Refractivity: 113.45 cm3; (15)Molar Volume: 284.8 cm3; (16)Polarizability: 44.97×10-24 cm3; (17)Surface Tension: 75.2 dyne/cm; (18)Density: 1.35 g/cm3; (19)Flash Point: 358.3 °C; (20)Enthalpy of Vaporization: 98.31 kJ/mol; (21)Boiling Point: 668.9 °C at 760 mmHg; (22)Vapour Pressure: 9.35E-18 mmHg at 25°C.
3. Structure Descriptors of Axitinib
(1)SMILES:O=C(NC)c4ccccc4Sc1ccc2c(c1)nnc2\C=C\c3ncccc3
(2)InChI:InChI=1/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+
(3)InChIKey:RITAVMQDGBJQJZ-FMIVXFBMBT
(4)Std. InChI:InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+
(5)Std. InChIKey:RITAVMQDGBJQJZ-FMIVXFBMSA-N
4. Uses of Axitinib
Axitinib (AG-013736) is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), platelet derived growth factor receptor (PDGFR), and cKIT (CD117). Axitinib inhibits many targets which is including VEGFR-1, VEGFR-2, VEGFR-3, platelet derived growth factor receptor (PDGFR), and cKIT (CD117). It also can inhibit growth of breast cancer in xenograft models and has been successful in trials with renal cell carcinoma (RCC) and several other tumor types. A Phase II clinical trial showed good response in combination chemotherapy with gemcitabine for advanced pancreatic cancer.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View